LLC Arensia Exploratory Medicine

The trials here

What the 5 trials at this site are about, from their registry records.

Conditions

• Chronic lymphocytic leukaemia1 trial
• Colorectal cancer1 trial
• Diffuse large B-cell lymphoma1 trial
• Epilepsy1 trial
• Follicular lymphoma1 trial
• Lung cancer1 trial
• Mantle cell lymphoma1 trial
• Metastatic breast cancer1 trial
• Prostate cancer1 trial
• Ulcerative colitis1 trial

Phase

• Phase 12 trials
• Phase 1/21 trial
• Phase 21 trial
• Phase 31 trial

Status

• Active, not recruiting3 trials
• Recruiting2 trials

Lead sponsor

• BioNTech SE1 trial
• Eli Lilly and Company1 trial
• Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc.1 trial
• IDEAYA Biosciences1 trial
• Xenon Pharmaceuticals Inc.1 trial

Running trials

• Recruiting

  A Study to Investigate the Safety, Pharmacokinetics, and Preliminary Efficacy of IDE574 Therapy in Adult Participants With Advanced Solid Tumors

  NCT07540572· Phase 1· IDEAYA Biosciences· Source

  Contact: IDEAYA Clinical Trials

• Recruiting

  A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast Cancer

  NCT06827236· Phase 1/2· BioNTech SE· Source

• Recruiting

  Dose Determining Study of EXS73565 in Participants With Relapsed or Refractory B-Cell Malignancies

  NCT06980116· Phase 1· Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc.· Source

  Contact: Exscientia AI Ltd.

• Active, not recruiting

  A Study to Evaluate XEN1101 as Adjunctive Therapy in Focal Epilepsy

  NCT03796962· Phase 2· Xenon Pharmaceuticals Inc.· Source

• Active, not recruiting

  A Study to Evaluate the Long-Term Efficacy and Safety of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 3)

  NCT03519945· Phase 3· Eli Lilly and Company· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Chronic lymphocytic leukaemia1 recruiting
• Diffuse large B-cell lymphoma1 recruiting
• Follicular lymphoma1 recruiting
• Mantle cell lymphoma1 recruiting
• Metastatic breast cancer1 recruiting